UniSuper Management Pty Ltd Boosts Stock Holdings in CVS Health Co. (NYSE:CVS)

UniSuper Management Pty Ltd lifted its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 26.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,677 shares of the pharmacy operator's stock after acquiring an additional 19,203 shares during the quarter. UniSuper Management Pty Ltd's holdings in CVS Health were worth $4,115,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Sava Infond d.o.o. acquired a new position in shares of CVS Health in the fourth quarter worth $424,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of CVS Health by 10.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,011,087 shares of the pharmacy operator's stock worth $92,047,000 after purchasing an additional 187,086 shares in the last quarter. Financial Engines Advisors L.L.C. bought a new position in CVS Health in the fourth quarter worth $366,000. Morey & Quinn Wealth Partners LLC acquired a new position in shares of CVS Health in the 4th quarter valued at $787,000. Finally, Ipsen Advisor Group LLC bought a new stake in CVS Health in the fourth quarter valued at about $303,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other CVS Health news, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael F. Mahoney bought 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the transaction, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.24% of the stock is owned by company insiders.

Remove Ads

Analysts Set New Price Targets

Several equities research analysts have recently commented on CVS shares. Wolfe Research boosted their target price on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 18th. Argus set a $77.00 price objective on CVS Health in a report on Tuesday, February 18th. Truist Financial boosted their target price on CVS Health from $60.00 to $76.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Finally, Piper Sandler boosted their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $70.39.

CVS Health Price Performance

CVS Health stock traded down $0.05 during trading hours on Wednesday, reaching $67.93. 1,877,881 shares of the stock were exchanged, compared to its average volume of 11,555,102. The stock has a 50 day moving average of $62.72 and a two-hundred day moving average of $57.83. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $75.27. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The company has a market cap of $85.65 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.92%. CVS Health's dividend payout ratio is 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.